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The serum level of IL-12 and IFN-g was also detected by
ELISA.
Results: Results of this study demonstrated that, 352
(9.5%) out of 3700 blood samples were HBsAg-/anti-HBc+
and HBV-DNA was detected in 57/352 (16.1%) of HBsAg-
/anti-HBc+ samples. Our results showed that groups showed
signiﬁcant difference in CC allele of +1188 region of IL-
12 and no difference was observed in the other evaluated
genes. Our results also showed that the alleles of +1188
region of IL-12 and alleles of +874 of IFN-g were also not
associated with serum level of cytokines.
Conclusion: According to the results of this study it may
be concluded that the polymorphisms in +1188 region of IL-
12 and +874 region of IFN-g would not affect the expression
of both cytokines at serum level in OBI patients.
doi:10.1016/j.ijid.2010.02.1987
53.006
Occult hepatitis B virus infection in ART-naive HIV-
infected Indian patients
S. Singh
All India Institute of Medical Sciences, New Delhi, India
Background: Hepatitis viruses are frequently found as a
co-infection with HIV due to shared routes of transmission.
Globally the most common method of diagnosis is serology,
which can only detect active HBV infection while the occult
HBV infection may be missed. We estimated the burden of
HBV infection in patients who were tested positive for HIV
at a tertiary care centre in north India. We also attempted
to determine the prevalence and clinical characteristics of
occult HBV among these treatment-naïve patients and com-
pare their demographics features with other HIV patients.
Methods: During a period of 6 years between January
2002 to December 2007 837 HIV positive patients were
tested for serological markers of HBV (HBsAg) and HCV IgM
in our laboratory. For comparison 428 apparently healthy,
HIV-negative organ donors were also included in the study.
Data on demographics, sexual behaviour, medical history,
laboratory tests viz., serum ALT and CD4 count of these
patients were recorded. A sub-group of 53 HBsAg negative
samples from HIV positive patients were randomly selected
and assessed for anti-HBs, anti-HBc total (IgG+IgM) and HBV-
DNA using a highly sensitive qualitative PCR and analysed
retrospectively.
Results: Overall, 7.3% of HIV positive patients showed
presence of HBsAg as compared to 1.4% in the HIV negative
control group. The prevalence was higher (8.55%) in males
than females (3.39%). Overall occult HBV with detectable
HBV-DNA was found in 37.5% patients; being 45.5% in anti-
HBs positive patients and 30.7% in patients positive for anti-
HBc antibodies alone.
Conclusion: High prevalence of HIV-HBV co-infection was
found in our patients. The most reliable method to diagnose
occult HBV co-infection in HIV seropositive patients is the
detection of HBV DNA.
doi:10.1016/j.ijid.2010.02.1988
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reatment of chronic hepatitis C: The efﬁcacy and pre-
ictors of response to therapy
. Bozic
Institute for Infectious and Tropic Diseases, Belgrade, SER-
IA, Serbia
Background: The current standard for therapy of chronic
epatitis C (CHC) is combination of pegylated interferon
lpha (PEG IFN-&2a or PEG IFN-&2b) and ribavirin (RBV). It
s universally accepted that achievement of Sustained Viro-
ogical Response (SVR) means successful treatment. Certain
actors are good predictors of treatment outcome and they
rovide optimal, individual therapeutic approach.
Objectives: Evaluation of efﬁcacy of CHC treatment and
redictors of treatment response.
Methods: 194 patients with CHC were treated with
ombination therapy (PEG IFN-&2a + RBV).Virological exam-
nations: anti-HCV antibodies (ELISA), serum HCV RNK levels
nd HCV genotypes (PCR technique). Liver biopsy specimens
ere staged in accordance with the Metavir score. Predic-
or with inﬂuence on treatment outcome were estimated by
ultivariable logistic regression analysis.
Results: There were more patients of male gender
59.3%), older then 40 years (58.2%), with high basal HCV-
NA level (> 800.000 IU/ml, 63%), with G1 HCV (67%) in
reated group of patients with CHC. Bridging ﬁbrosis and cir-
hosis (F3, F4) were found in 54 (27.8%) of patients. SVR was
chieved in 69.2%, relapse was found in 11.9% of patients.
9.8% of patients had no response on therapy. Predictors for
chievement of SVR were: non-1 HCV genotype p = 0.002,
R 5.9 95% CI (1.9—18.0), achievement of early virologi-
al response (EVR) p = 0.000, OR 0.92, 95% CI (2.73—35.97),
nd patients younger the 40 years p = 0.005, OR 3.66 95% CI
1.48-9.0). Predictors for failure of therapy for patients who
idn’t respond to treatment were: G1 HCV p = 0.005, OR 3.9,
5 CI (1.5—10.3), high basal viral load p = 0.013, OR 3.45,
5% CI (1.29—9.19) and interupted continuity of treatment
= 0.002, OR 4.49, 95% CI (1.72—11.76).
Conclusion: The current standard antiviral therapy was
fﬁcient in 127/194 (69.2%) of our patients. The most impor-
ant predictors for successful treatment (SVR) were: non-1
CV genotype, achievement of EVR for G1 HCV and patients
ge. Predictors for failure of treatment were: G1 HCV, high
asal viral load, older age (>40 years), presence of cirrhosis
nd discontinuity of treatment.
oi:10.1016/j.ijid.2010.02.1989
3.008
ccult hepatitis C virus infection among chronic liver dis-
ase patients in the United Arab Emirates
. Al-Moslih
University of Sharjah, P.O.Box 27272, Sharjah, United Arab
miratesBackground: Viral Hepatitis C (HCV) is one of the major
orld wide health problems. WHO estimates that about 3%
f the world’s population has been infected with HCV and
hat some 170 million are chronic carriers at risk of develop-
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ng liver cirrhosis and/or liver cancer. Occult hepatitis C virus
OCV) infection is characterized by presence of HCV infec-
ion with undetectable hepatitis C antibodies or/and RNA
n serum. Scanty information is available about the etiology
f viral chronic liver diseases in the United Arab Emirates
UAE). Therefore a study was carried out for detecting and
enotyping of HCV & OCV in patients with chronic liver dis-
ase (CLD) in UAE.
Methods: A total of 142 serum samples from CLD patients
nd 139 healthy individuals were tested by polymerase chain
eaction (PCR) & (RT-PCR) in determining HCv RNA&HBVDNA
n serum samples. ELISA tests were used to detect HCV & HBV
arkers in patient sera. Liver biopsies were taken from CLD
atients for immunohistochemistry((IHC) staining.
Results: The results indicated the prevalence of HCV,
ccult HCV, dual (HBV &HCV) and HBV infections at a
ate of 43.7%, 27.5%, 19.0% and 12.7% in CLD patients
espectively. Were as Healthy subjects were positive for
nti body HCV and HBV-DNA at a rate of 3.6% and 2.2%
espectively (P = 0.001). The most prevalent genotypes and
ubtypes of of HCV infection in CDL patients were genotype 4
28.3%),Where as the prevalence of other genotypes,3a,1a,
nd 3b,1b, 5, 2, 3a & 3b, 2a and 1a & 1b were in the range of
5.3 to 1.3%. IHC results for HCV in biopsy tissues revealed
hat 84.6 (11/13) were positive. Histopathological studies of
iver biopsies revealed that patients with HCV infection were
ore likely to have necroinﬂammatory activity and ﬁbrosis
han patients without HCV infection.
Conclusion: Occult HCV is relatively frequent among
atients with CLD in the UAE. Phylogenetic tree showed that
enotype 4 appears to be the dominant genotype Where as
he prevalence of other genotypes that circulating in UAE
opulation.(1b, 5, 2, 3a & 3b, 2a and 1a &1b) were less
ominant than genotype 4.
oi:10.1016/j.ijid.2010.02.1990
3.009
linical features of acute viral hepatitis A complicated
ith acute renal failure
. Choi ∗, B.S. Chin, S.Y. Shin, S.J. Jin, Y.T. Chae, S.H. Han,
.-H. Baek, J.Y. Choi, C.O. Kim, J.M. Kim
Yonsei University College of Medicine, Seoul, Korea, Repub-
ic of
Background: Although acute hepatitis A is usually self-
imited, the clinical manifestations can vary from mild to
evere liver dysfunction. However, little is known about risk
actors and outcome predictors for acute renal failure (ARF)
n acute hepatitis A. The objective of this study was to iden-
ify the simple clinical predictors for acute renal failure
ARF) and its clinical course.
Methods: The study and control groups consisted of
atients who did or did not develop acute renal failure,
espectively, after acute hepatitis A from January 2006 to
une 2009. A total of 396 patients were enrolled in this
tudy. We conducted a retrospective analysis of the inci-
ence, risk factors, and outcomes of patients with acute
epatitis A complicated with ARF.
Results: Thirty patients (7.6%) developed ARF. Older
atients and males were more likely to ARF during hepati-
a
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is A. ARF patients were more likely obese, heavy alcoholics
nd having fulminant course. The ARF patients had a higher
hite blood cell count, higher levels of AST, ALT, total
ilirubin and CRP, lower levels of albumin, more frequent
oagulopathy, and lower platelet count compared with the
thers. On multivariate analysis, male gender [Odds ratio
OR) 9.616, 95% conﬁdence interval (CI) 1.307—70.000,
= 0.026], the presence of hypertension [OR 5.91, 95%
I 1.407-24.824, P = 0.015] and fulminant hepatitis [OR
7.95, 95% CI 10.399—322.928, P < 0.001] were indepen-
ent risk factors of hepatitis A-associated ARF. Of the 30
atients with ARF, 23 (76.7%) patients fully recovered; 14
46.7%) patients recovered with conservative care only,
nd nine (30%) patients required short-term hemodialysis.
he two groups of spontaneous recovery from ARF (n = 14)
nd hemodialysis/death (n = 16) showed signiﬁcant differ-
nces in platelet count at its worst value, creatinine at
ts worst value, albumin at admission, INR at admission
nd fulminant hepatic failure. Albumin level at admission
igher than 3.6mg/dL [OR 13.183, 95% CI 1.064-163.403,
= 0.045] and INR at admission less than 1.6 [OR 14.969,
5% CI 1.346-166.447, P = 0.028] were independent predic-
ors of spontaneous recovery of ARF during acute hepatitis
.
Conclusion: Acute renal failure associated with acute
epatitis A is not a rare complication. Male gender and
ypertension are risk factors of ARF. Patients complicated
ith ARF, higher albumin level and shorter INR at admission
ould a favorable prognostic factor.
oi:10.1016/j.ijid.2010.02.1991
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revalence of isolated hepatitis B core antibody among
njection drug users in Central Province of Iran
. Soﬁan1,∗, A. Rostampour2, N. Izadi3, F.S. Mahdaviani3,
.A. Farazi 1, A. Ramezani4, N. Zarinfar5, H. Sarmadian6,
. Aghakhani7, M. Banifazl 7
Arak University of Medical Sciences, Arak, Iran, (Islamic
epublic of)
Islamic Azad University of Arak Branch, Arak, Iran, (Islamic
epublic of)
Iranian Blood Transfusion Research Center, Arak, Iran,
Islamic Republic of)
Pasteur Institute of Iran, Tehran, Iran, (Islamic Republic
f)
Arak medica university, Arak, Iran, (Islamic Republic of)
Arak University of Medical science, Arak, Iran, (Islamic
epublic of)
Tehran, Iran, (Islamic Republic of)
Background: Prevalence of hepatitis B virus (HBV), hep-
titis C virus (HCV) and co-infection of HBV and HCV are high
mong injection drug users. Hepatitis B may be presented
nly with isolated Hepatitis B core antibody (anti-HBc). This
tudy aimed to determine the prevalence of isolated anti-
Bc among injection drug users in central province of Iran
nd comparison of its prevalence with healthy blood donors.
Methods: A total of 531 voluntary blood donors with mean
ge of 36± 10.18 years (range 16—60 years) and 153 injec-
ion drug users with mean age of 30.66± 5.92 years (range
